This phenomenon may be explained by the specific nature of the pathophysiological defect in NDM; unlike type 2 diabetes (where multiple factors promote glycaemic dysfunction), other physiological regulators of insulin secretion (glucagon like peptide 1, GLP-1, etc.) function normally. Here, INS is linked to type 2 diabetes mellitus.